Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.364% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCOP(=O)(OCC)C(NC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1)C(F)(F)F
b: CSc1nc(C)cc(OCCNS(=O)(=O)c2cc(C)ccc2C)n1
Answer: b. CSc1nc(C)cc(OCCNS(=O)(=O)c2cc(C)ccc2C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1nc(C)cc(OCCNS(=O)(=O)c2cc(C)ccc2C)n1
CSc1nc(C)cc(OCCNS(=O)(=O)c2cc(C)ccc2C)n1
2,5-dimethyl-N-[2-(6-methyl-2-methylsulfanylpyrimidin-4-yl)oxyethyl]benzenesulfonamide